Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Twist Bioscience Corp TWST

Healthcare Biotechnology
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of... see more

Recent & Breaking News (NDAQ:TWST)

Twist Bioscience to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on Friday, November 18, 2022

Business Wire November 3, 2022

Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research

Business Wire November 2, 2022

Twist Bioscience Promotes Patrick Finn, Ph.D., to President and Chief Operating Officer

Business Wire October 26, 2022

Twist Bioscience Launches Human Sample ID Kit to Track Whole Blood Samples Through Lab Testing Workflow

Business Wire October 18, 2022

Twist Bioscience Earns 2022 Great Place to Work Certification

Business Wire October 12, 2022

Twist Bioscience to Present at JSNN NanoImpacts 2022

Business Wire October 5, 2022

The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia

Business Wire September 20, 2022

Twist Bioscience to Present at Baird 2022 Global Healthcare Conference

Business Wire September 6, 2022

Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results

Business Wire August 5, 2022

Twist Bioscience to Present at Flash Memory Summit

Business Wire August 3, 2022

Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market

Business Wire August 2, 2022

Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2

Business Wire August 2, 2022

Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit

Business Wire August 1, 2022

Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022

Business Wire July 18, 2022

Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls

Business Wire July 14, 2022

DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow

Business Wire July 13, 2022

Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity

Business Wire July 6, 2022

Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology

Business Wire June 30, 2022

Twist Bioscience to Present at Fujifilm's 12th Annual Global IT Executive Summit

Business Wire June 16, 2022

Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening

Business Wire June 7, 2022